Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease
To access this article, please choose from the options below
PII: S0197-4580(05)00215-0
doi:10.1016/j.neurobiolaging.2005.07.015
© 2005 Elsevier Inc. All rights reserved.
